R&D Leadership During the Pandemic
Summary: Top R&D execs discuss how they’ve reorganized global teams, tapped new programs as a priority to fight COVID-19 and plan for the future after the pandemic has passed. View this fireside chat with Endpoints Founder John Carroll and Laurie H. Glimcher, President and CEO of the Dana-Farber Cancer Institute followed by a panel discussion from leaders at GlaxoSmithKline, Takeda, Amgen, Johnson & Johnson and Catalent’s Chair & CEO, John Chiminski.